Imris has received a Health Canada medical device licence for its AccuTrack 3D image guidance tool, for use in Imris neurosurgery suites.
The tool will enable surgeons to localise target anatomy before and at any time during a neurosurgical procedure.
The imaging system allows a high-field MR scanner to move into an operating room on demand before, during and after procedures without moving the patient, which ensures a high degree of safety in the surgical environment and for the patient.
AccuTrack previously received CE mark regulatory approval in Europe and is FDA 510(k) pending in the US.
